FDA OKs Pfizer drug for rare, fast-killing type of leukemia – New Jersey Herald
New Jersey Herald |
FDA OKs Pfizer drug for rare, fast-killing type of leukemia
New Jersey Herald FILE – In this Monday, Nov. 23, 2015, file photo, a Pfizer flag is displayed in front of the company’s world headquarters in New York. The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer … FDA Approves New Acute Lymphoblastic Leukemia Treatment FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia FDA Approves Inotuzumab Ozogamicin (Besponsa) for ALL |
View original article
Author:
Powered by WPeMatico